Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

NCT05743985 is registered in ClinicalTrials.gov with Formula30A LLC as lead sponsor.

NCT NCT05743985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05743985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults
Lead sponsor
Formula30A LLC
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2022
Completion date
April 30, 2024
Enrollment
69 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect, health, subjective, inflammatory response, side effect